Forensic Analysis · General / Diversified · as of Jun 27, 2026
Bausch & Lomb Corp (BLCO)
A forensic read on Bausch & Lomb Corp built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.
D · Weak — demands caution
Forensic grade
Grey Zone
Financial health
1.2
Altman Z-score
Clean
Earnings quality
3
Forensic signals
-3.4%
ROE
$5.8B
Market cap
Bausch & Lomb Corp earns a D (Weak — demands caution) forensic quality grade, and its Altman Z-score is 1.2, placing it in the Grey zone. 3 forensic signals were flagged in its latest SEC filings, led by return on invested capital.
What the filings flag
1%Return on invested capital.Return on invested capital is 1% and steady — well below its ~9% cost of capital, so reinvested dollars may be destroying value, not building it.
87d DSOReceivables vs revenue.Days sales outstanding moved from 78 to 87 days FY2024→FY2025 (receivables +19% vs revenue +6%). Receivables are creeping up relative to sales — watch the trend.
+0.3%/yrShare-count dilution.Diluted share count changed +1% over the last 3 years to FY2025 (+0.3%/yr). Roughly flat — buybacks are about offsetting stock comp, not shrinking the count. Per-share value isn't being meaningfully helped or hurt by the count.
Key fundamentals
Net Margin-7.1%
Debt / Equity0.78x
Free Cash Flow$-66.0M
Latest Revenue$5.10B
Return on Equity-5.6%
Revenue Growth YoY+6.5%
Go deeper — free with an account
The forensic grade and screens above are free — no account needed. An account adds the full interactive deep-dive on Bausch & Lomb Corp:
🔒The written investment read — what the numbers mean, in plain English
🔒Ask anything about BLCO's filings — AI Q&A across the 10-K, 10-Qs & 8-Ks
🔒Interactive valuation — reverse-DCF sliders, Monte Carlo & scenario stress
🔒Calibrated 12-month price forecast, with the math shown